erythromycin propionate-n-acetylcysteinate has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, F; Li, Y; Lu, W; Sun, X; Wang, Y; Xiang, L; Xu, X; Zhao, Y; Zhou, L | 1 |
1 other study(ies) available for erythromycin propionate-n-acetylcysteinate and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Activation of the Epac/Rap1 signaling pathway alleviates blood-brain barrier disruption and brain damage following cerebral ischemia/reperfusion injury.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Brain Injuries; Brain Ischemia; Guanine Nucleotide Exchange Factors; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction | 2023 |